1,080 material Form 8-K filings that 839 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
CooperCompanies reported fiscal second-quarter 2025 results for the period ended April 30, 2025, with revenue up 6% to $1,002.3 million and non-GAAP diluted EPS up 14% to $0.96. GAAP diluted EPS was $0.44, flat from a year earlier, and the company updated its fiscal 2025 guidance, though the filing does not show the prior guidance for comparison. The company also repurchased $40.6 million of common stock during the quarter.
Revenue of $1,002.3 million, up 6% from $942.6 million a year earlier, and up 7% organically.
GAAP diluted EPS of $0.44, flat year over year; non-GAAP diluted EPS of $0.96, up from $0.85.
Updated fiscal 2025 guidance: total revenue of $4,107 million to $4,146 million and non-GAAP diluted EPS of $4.05 to $4.11.
Repurchased $40.6 million of stock at an average price of $75.60; $215.8 million of authorization remains.
Gap Inc. reported first quarter fiscal 2025 results for the period ended May 3, 2025, with net sales of $3.5 billion, up 2% from a year earlier, and operating income of $260 million, up from $205 million. Diluted earnings per share were $0.51, compared with $0.41 a year earlier. The company's full-year outlook projects net sales growth of 1% to 2% and operating income growth of 8% to 10%, excluding an estimated $100 million to $150 million net impact from current tariffs.
Net sales were $3.5 billion ($3,463 million), up 2%, with comparable sales up 2%.
Operating income was $260 million, up from $205 million, for an operating margin of 7.5%.
Diluted EPS was $0.51 versus $0.41 a year earlier; net income was $193 million.
Fiscal 2025 outlook: net sales growth of 1% to 2%; operating income growth of 8% to 10% before an estimated $100 million to $150 million net tariff impact; second quarter net sales approximately flat.
UiPath reported fiscal first quarter 2026 results for the period ended April 30, 2025, with revenue of $357 million, up 6% year over year, and ARR of $1.693 billion, up 12%. The GAAP net loss narrowed to $23 million from $29 million a year earlier, and the company issued second-quarter and full-year revenue ranges, which set expectations for shareholders.
Revenue of $357 million, up from $335 million in the same quarter last year
GAAP operating loss of $16 million, compared with a $49 million loss a year earlier
Second-quarter revenue guidance of $345 million to $350 million; full-year fiscal 2026 revenue guidance of $1.549 billion to $1.554 billion
Ulta Beauty reported first-quarter fiscal 2025 results for the period ended May 3, 2025, with net sales up 4.5% to $2.8 billion and diluted earnings per share of $6.70, versus $6.47 a year earlier. Net income fell to $305.1 million from $313.1 million, and operating margin declined to 14.1% from 14.7%. The company raised its fiscal 2025 diluted EPS outlook to $22.65 to $23.20 from $22.50 to $22.90.
Net sales rose 4.5% to $2.8 billion; comparable sales increased 2.9%, driven by a 2.3% rise in average ticket and a 0.6% rise in transactions.
Diluted EPS was $6.70 versus $6.47, while net income declined to $305.1 million from $313.1 million and the effective tax rate rose to 24.6% from 23.2%.
Fiscal 2025 outlook: diluted EPS raised to $22.65 to $23.20 from $22.50 to $22.90; net sales raised to $11.5 billion to $11.7 billion; comparable sales raised to 0% to 1.5%.
Share repurchases of $358.7 million in the quarter; $2.3 billion remained under the $3.0 billion program as of May 3, 2025.
NetApp reported fourth-quarter fiscal 2025 net revenues of $1.73 billion, up 4% from a year earlier, and GAAP net income of $340 million, or $1.65 per share, compared with $291 million and $1.37 a year earlier. The company guided fiscal 2026 net revenues to $6.625 billion to $6.875 billion and authorized up to an additional $1.1 billion in share repurchases, while Executive Vice President and Chief Product Officer Harvinder Bhela plans to leave that role by June 20, 2025.
Q4 fiscal 2025 net revenues $1.73 billion, up 4% year over year; GAAP EPS $1.65 vs. $1.37
Fiscal 2026 net revenue guidance $6.625 billion to $6.875 billion; GAAP EPS guidance $5.80 to $6.10
Board authorized up to an additional $1.1 billion in stock repurchases on May 22, 2025, with no expiration date
Chief Product Officer Harvinder Bhela to transition out of his role by June 20, 2025
Bath & Body Works reported first quarter 2025 net sales of $1,424 million, up 2.9%, and earnings of $0.49 per diluted share, up from $0.38, with EPS above the high end of its guidance range. The company maintained its full-year 2025 guidance and gave second quarter EPS guidance of $0.33 to $0.38, and it said the CEO transition could reduce 2025 EPS by about $0.05, which its guidance excludes.
Q1 net sales $1,424 million, up 2.9% from $1,384 million; diluted EPS $0.49 vs. $0.38, above the high end of guidance.
Full-year 2025 guidance maintained: net sales growth of 1% to 3% and diluted EPS of $3.25 to $3.60, including current tariff rates.
Q2 2025 guidance: net sales flat to up 2%; diluted EPS of $0.33 to $0.38, vs. $0.37 adjusted EPS in Q2 2024.
Daniel Heaf appointed CEO effective May 16, 2025; the company estimates the transition could reduce 2025 EPS by about $0.05.
Hamilton Lane reported fourth-quarter and full fiscal 2025 results for the year ended March 31, 2025. Full-year management and advisory fees rose 14% to $513.9 million and GAAP net income rose 54% to $217.4 million, while fourth-quarter GAAP EPS slipped 2% year over year. The company also declared a quarterly dividend of $0.54 per share and set a full-year dividend target of $2.16, up 10%.
Full-year GAAP diluted EPS was $5.41, up 47% from $3.69 in fiscal 2024
Fourth-quarter GAAP diluted EPS was $1.23 versus $1.26 a year earlier; non-GAAP EPS was $1.21 versus $1.38
Assets under management reached $138 billion at March 31, 2025, up 11% year over year
Quarterly dividend of $0.54 per share is payable July 7, 2025 to holders of record on June 20, 2025
Burlington Stores reported first-quarter fiscal 2025 results for the period ended May 3, 2025, with total sales up 6% to $2.5 billion and diluted EPS of $1.58 versus $1.22 a year earlier. Adjusted EPS of $1.67 was well ahead of company guidance, but the CEO said about half of that beat reflects expense timing that will weigh on the second quarter, and he warned tariffs will pressure merchandise margins. The company maintained full-year adjusted EPS guidance of $8.70 to $9.30.
Total sales rose 6% to $2.5 billion, while comparable store sales were flat.
Net income was $101 million, or $1.58 per diluted share, versus $79 million, or $1.22, a year earlier.
Adjusted EPS rose 18% to $1.67, excluding bankruptcy acquired lease expenses; full-year adjusted EPS guidance of $8.70 to $9.30 was maintained.
On May 20, 2025, the Board authorized up to an additional $500 million of common stock repurchases, executable through May 2027.
Synopsys reported second-quarter fiscal 2025 revenue of $1.604 billion, up from $1.455 billion a year earlier, and GAAP net income of $349.2 million, or $2.24 per diluted share, versus $1.92 a year earlier. The company reaffirmed its full-year 2025 revenue and non-GAAP operating margin guidance, which gives shareholders a clear view of the company's expected results for the rest of the fiscal year.
Q2 revenue was $1.604 billion versus $1.455 billion in the prior-year quarter; the company said this exceeded the midpoint of its guidance
Non-GAAP earnings per diluted share were $3.67, versus $3.00 a year earlier; GAAP earnings per diluted share were $2.24, versus $1.92
Full-year fiscal 2025 revenue target of $6.745 billion to $6.805 billion was reaffirmed; third-quarter revenue target is $1.755 billion to $1.785 billion
Synopsys said final second-quarter financial statements will be included in its Form 10-Q, due on or before June 9, 2025
Pure Storage reported first quarter fiscal 2026 revenue of $778.5 million, up 12% year over year, and a GAAP net loss of $14.0 million, narrower than the $35.0 million loss a year earlier. The company also said Chief Financial Officer Kevan Krysler will leave, and that he will stay until a successor is named and that the departure does not relate to financial statement or accounting issues.
Revenue $778.5 million, up 12% year over year; subscription services revenue $406.3 million, up 17%
GAAP operating loss of $31.2 million, versus $41.8 million a year earlier; non-GAAP operating income $82.7 million
Guidance: second quarter revenue of $845 million; fiscal 2026 revenue of $3.515 billion, up 11%
CFO Kevan Krysler to leave; he remains until a successor is named
Veeva Systems reported fiscal 2026 first-quarter revenue of $759.0 million, up 17% from a year earlier, and GAAP net income of $228.2 million, up 41%. The company also gave fiscal 2026 revenue guidance of $3,090 million to $3,100 million and second-quarter revenue guidance of $766 million to $769 million, which matters to shareholders because it sets the near-term outlook for sales and profit.
Total revenues were $759.0 million, up from $650.3 million a year earlier; subscription services revenues were $634.8 million, up 19%.
GAAP diluted net income per share was $1.37, compared with $0.98 a year earlier; non-GAAP diluted net income per share was $1.97, compared with $1.50.
Fiscal 2026 revenue guidance is $3,090 million to $3,100 million; non-GAAP operating income is about $1,360 million.
Second-quarter guidance covers revenue of $766 million to $769 million, ending July 31, 2025.
Nutanix reported third-quarter fiscal 2025 results for the period ended April 30, 2025, with revenue of $639.0 million, up 22% from a year earlier, and annual recurring revenue of $2.14 billion, up 18%. The company swung to GAAP operating income of $48.6 million from a loss of $11.6 million a year earlier, and it set fourth-quarter and full-year fiscal 2025 outlook ranges.
Q3 revenue $639.0 million vs. $524.6 million a year earlier (up 22%)
GAAP operating income $48.6 million vs. a loss of $11.6 million a year earlier; GAAP diluted EPS $0.22 vs. $(0.06)
Free cash flow $203.4 million vs. $78.3 million; fiscal 2025 free cash flow outlook $700 million to $730 million
Q4 fiscal 2025 revenue outlook $635 million to $645 million; full-year fiscal 2025 revenue outlook $2.52 billion to $2.53 billion
On May 21, 2025, Greenbrier amended its credit agreement with Bank of America, extending its $600 million revolving facility and $250 million term loans to May 21, 2030. The amendment also raised several negative covenant limits, including the dividend basket to $1.28 per share per fiscal year and the share repurchase basket to $50 million per fiscal year, which gives the company more room to pay dividends and buy back shares.
Revolving facility of up to $600.0 million and $250 million in term loans both extended to May 21, 2030.
Term loans to be repaid in quarterly installments of $3,125,000, starting September 30, 2025.
Dividend basket raised from $1.08 to $1.28 per share per fiscal year; share repurchase basket raised from $25 million to $50 million per fiscal year.
Castings LLC and Greenbrier Tank Components, LLC joined as guarantors and debtors under the existing facility.
Semtech reported first-quarter fiscal 2026 results for the quarter ended April 27, 2025, with net sales of $251.1 million, up 22% from $206.1 million a year earlier, and GAAP diluted earnings per share of $0.22 versus a loss of $0.36 a year ago. The company also gave second-quarter net sales guidance of $256.0 million plus or minus $5.0 million and adjusted diluted EPS guidance of $0.40 plus or minus $0.03.
Net sales of $251.1 million, up 22% from $206.1 million in Q1 2025 and roughly flat from $251.0 million in Q4 2025.
GAAP diluted EPS of $0.22 versus a loss of $0.36 a year ago; adjusted diluted EPS of $0.38 versus $0.06 a year ago and $0.40 in Q4 2025.
Second-quarter fiscal 2026 outlook: net sales of $256.0 million plus or minus $5.0 million; adjusted diluted EPS of $0.40 plus or minus $0.03.
Debt reduction: a $10 million term loan principal prepayment in Q1 and an additional $15 million to date in Q2, according to CFO Mark Lin.
Okta reported results for the fiscal first quarter ended April 30, 2025, with total revenue of $688 million, up 12% year-over-year, and GAAP net income of $62 million, compared with a GAAP net loss of $40 million a year earlier. The company also gave fiscal 2026 full-year revenue guidance of $2.850 billion to $2.860 billion, representing 9% to 10% growth, and second-quarter revenue guidance of $710 million to $712 million.
Q1 fiscal 2026 GAAP diluted net income per share was $0.35, versus a loss of $0.24 a year earlier; non-GAAP diluted EPS was $0.86, versus $0.65.
Non-GAAP operating income was $184 million, or 27% of total revenue, versus $133 million, or 22%, a year earlier.
Operating cash flow was $241 million and free cash flow was $238 million for the quarter.
Full-year fiscal 2026 non-GAAP operating income is expected at $710 million to $720 million, a 25% margin.
Champion Homes reported fiscal fourth-quarter results for the period ended March 29, 2025, with net sales up 10.7% to $593.9 million and net income up $33.6 million to $36.3 million. Adjusted EBITDA fell 1.1% to $52.6 million, and the board refreshed the share repurchase authorization to provide for $100 million of potential future repurchases.
Q4 net sales rose 10.7% to $593.9 million; U.S. homes sold rose 5.1% to 5,941.
Q4 diluted EPS was $0.63 versus $0.05 a year earlier, when results included a $34.5 million water intrusion product liability reserve.
Q4 Adjusted EBITDA fell 1.1% to $52.6 million; margin was 8.9% versus 9.9%.
Full-year fiscal 2025 net income was $198.4 million and diluted EPS was $3.42; the company repurchased $20.0 million of stock in Q4.
Buckle reported results for the fiscal quarter ended May 3, 2025, with net income of $35.2 million, or $0.70 per diluted share, up from $34.8 million, or $0.69 per diluted share, a year earlier. Net sales rose 3.7% to $272.1 million, and both comparable store sales and online sales increased, which points to higher sales and profit for shareholders in the quarter.
Net sales rose 3.7% to $272.1 million from $262.5 million a year earlier.
Diluted EPS was $0.70 versus $0.69 in the prior-year quarter; net income was $35.2 million versus $34.8 million.
Comparable store net sales increased 3.0%, and online sales rose 4.5% to $46.4 million.
Buckle operated 439 stores in 42 states at quarter end, compared with 440 stores in 42 states a year earlier.
Booz Allen reported fiscal 2025 results for the year ended March 31, 2025, with revenue of $12.0 billion, up 12.4%, and GAAP diluted EPS of $7.25, up from $4.59. The company also projected fiscal 2026 revenue of $12.0 billion to $12.5 billion and adjusted diluted EPS of $6.20 to $6.55, compared with $6.35 in fiscal 2025.
FY2025 revenue was $12.0 billion, up 12.4% year over year; adjusted diluted EPS was $6.35, up 15.5%.
GAAP diluted EPS was $7.25 versus $4.59 a year earlier; net income was $935 million versus $606 million.
FY2026 guidance: revenue of $12.0 billion to $12.5 billion (0% to 4.0% growth) and adjusted diluted EPS of $6.20 to $6.55.
Quarterly dividend of $0.55 per share is payable June 27, 2025, to holders of record on June 11, 2025.
Cavco Industries reported fiscal fourth-quarter 2025 net revenue of $508 million, up 21% from a year earlier, and diluted earnings per share of $4.47 versus $4.03. The board also approved a new $150 million stock repurchase program on May 20, 2025, which the company expects to fund from existing cash.
Q4 net revenue was $508 million, up 21% from $420 million; GAAP diluted EPS was $4.47 versus $4.03.
Adjusted diluted EPS was $5.40, excluding a $10.0 million non-cash charge tied to legacy brand intangibles.
The board approved a new $150 million stock repurchase program on May 20, 2025; timing and amount are at the company's discretion and it may be suspended at any time.
Victoria's Secret & Co. signed Amendment No. 2 to its senior secured asset-based revolving credit facility with JPMorgan Chase Bank, N.A. as agent on May 21, 2025. The amendment extends the facility's maturity, lowers borrowing rates, and adds seasonal flexibility on inventory advance rates, which changes the terms of the company's existing borrowing capacity.
Amendment No. 2 to the August 2, 2021 Revolving Credit Agreement was dated May 21, 2025.
Interest rate on term SOFR or term CORRA loans reduced to 1.50% to 1.75%; alternate base rate loans reduced to 0.50% to 0.75%.
Maturity extended to five years after the amendment closing date, subject to a springing test tied to debt over $50 million.
Seasonal advance rate on eligible inventory rises from 90.0% to 92.5% for three consecutive fiscal months during high season.
Copart reported results for the third quarter of fiscal 2025, which ended April 30, 2025. Revenue reached $1.2 billion, up 7.5% from a year earlier, and net income attributable to Copart rose 6.4% to $406.6 million. Diluted earnings per share were $0.42, compared with $0.39 a year earlier, so per-share profit grew faster than net income.
Quarterly revenue was $1.2 billion, up $84.5 million or 7.5% year over year.
Gross profit was $552.3 million, up 5.1%; net income attributable to Copart was $406.6 million, up 6.4%.
Diluted EPS was $0.42 versus $0.39 last year, an increase of 7.7%.
Nine-month revenue was $3.5 billion, up 11.2%, and diluted EPS was $1.18 versus $1.07, up 10.3%.
Deckers reported fiscal 2025 net sales up 16.3% to $4.986 billion and diluted EPS up 30% to $6.33, and gave a first-quarter fiscal 2026 outlook but no full-year guidance because of trade policy uncertainty. The board also raised the share repurchase authorization by $2.25 billion to about $2.5 billion and named Cynthia Davis Chair, succeeding Michael Devine III, who is retiring.
Fiscal 2025 net sales rose 16.3% to $4.986 billion; diluted EPS rose to $6.33 from $4.86.
Fourth-quarter net sales rose 6.5% to $1.022 billion; diluted EPS was $1.00 versus $0.82.
First-quarter fiscal 2026 outlook: net sales of $890 million to $910 million and diluted EPS of $0.62 to $0.67; no full-year fiscal 2026 guidance was given.
Buyback authorization increased by $2.25 billion to about $2.5 billion; Cynthia Davis became Chair effective May 22, 2025.
Intuit reported revenue of $7.8 billion for the fiscal third quarter ended April 30, 2025, up 15 percent, and raised its full-year fiscal 2025 guidance across total company metrics. The company also declared a quarterly dividend of $1.04 per share.
Q3 revenue of $7.8 billion, up 15 percent; GAAP diluted EPS of $10.02, up 19 percent; non-GAAP diluted EPS of $11.65, up 18 percent
Fiscal 2025 revenue guidance of $18.723 billion to $18.760 billion, growth of about 15 percent, up from prior guidance of 12 to 13 percent
Fiscal 2025 non-GAAP diluted EPS guidance of $20.07 to $20.12, up from prior growth guidance of 13 to 14 percent
Dividend of $1.04 per share payable July 18, 2025, to holders of record as of July 10, 2025
Ralph Lauren reported fourth-quarter and full-year fiscal 2025 results, with revenue and reported earnings per share both higher than a year earlier. The company also raised its quarterly dividend 10% and approved a new $1.5 billion share repurchase program, and it gave a preliminary fiscal 2026 outlook calling for low-single-digit constant-currency revenue growth.
Q4 revenue rose 8% to $1.7 billion on a reported basis and 10% in constant currency
Q4 reported EPS was $2.03 versus $1.38 a year earlier; adjusted EPS was $2.27 versus $1.71
Full-year fiscal 2025 revenue rose 7% to $7.1 billion; reported EPS was $11.61 versus $9.71
Quarterly dividend increased 10% to $0.9125 per share; new $1.5 billion repurchase program authorized
BJ's Wholesale Club reported first quarter fiscal 2025 results for the thirteen weeks ended May 3, 2025. Net sales rose 4.7% to $5.03 billion, net income rose 34.9% to $149.8 million, and diluted EPS was $1.13 versus $0.83 a year earlier. The company left its fiscal 2025 guidance unchanged, including adjusted EPS of $4.10 to $4.30.
Diluted EPS of $1.13 versus $0.83; adjusted EPS of $1.14 versus $0.85 a year earlier
Comparable club sales rose 1.6%; excluding gasoline sales, they rose 3.9%
Fiscal 2025 adjusted EPS guidance of $4.10 to $4.30, first given March 6, 2025, left unchanged
Repurchased 55,000 shares for $6.2 million in the first quarter
CSW Industrials reported record fiscal fourth-quarter 2025 revenue of $230.5 million, up 9.3%, with GAAP net income of $35.1 million and adjusted EPS of $2.24 versus $2.04 a year earlier. Full-year revenue rose 10.8% to $878.3 million, and adjusted EBITDA reached $227.9 million. For shareholders, revenue and profit both rose, though the Specialized Reliability Solutions segment's operating income fell 33.7% in the quarter.
Q4 revenue $230.5 million, up 9.3%, including 6.3% inorganic growth from acquisitions and 3.0% organic growth
GAAP net income attributable to CSWI $35.1 million; adjusted EPS $2.24 versus $2.04, up 9.8%
Full-year revenue $878.3 million, up 10.8%; adjusted EBITDA $227.9 million, up 13.9%
Aspen Manufacturing acquired for $313.5 million, closed May 1, 2025; stock moves to NYSE June 9, 2025 under ticker CSW
CorVel reported results for the three months and fiscal year ended March 31, 2025, with revenue and earnings per share both higher than a year earlier. For the quarter, revenue rose to $232 million and diluted EPS rose to $0.51 from $0.37, and the company repurchased $9.0 million of common stock. The results show growth in both sales and profit for shareholders.
Q4 revenue was $232 million, up 12% from $207 million a year earlier.
Q4 diluted EPS was $0.51, up 38% from $0.37; gross profit rose 34% to $58.0 million at a 25% gross margin.
Fiscal year revenue was $896 million, up from $795 million, and fiscal year diluted EPS was $1.83, up from $1.47.
The company ended the quarter with $171 million of cash and no borrowings, and repurchased $9.0 million of stock during the quarter.
Mosaic entered into an Amended and Restated Credit Agreement effective May 16, 2025, with Bank of America as administrative agent, replacing its existing credit agreement. The unsecured revolving credit facility provides up to $2.5 billion and extends maturity from August 19, 2026 to May 16, 2030, while reducing unused commitment fees and adding covenant flexibility.
Unsecured revolving credit facility of up to $2.5 billion
Maturity extended from August 19, 2026 to May 16, 2030
Unused commitment fee rates reduced compared with the existing agreement
Full agreement filed as Exhibit 10.1; Bank of America, N.A. is administrative agent
On May 16, 2025, a U.S. District Court in Delaware ruled in Acadia's favor on both infringement and validity in its '721 formulation patent case over Nuplazid (pimavanserin) against Aurobindo and MSN. The same week, Acadia agreed to a 12-year, two-month lease for about 52,771 square feet in Princeton, New Jersey, and will end its current 502 Carnegie Center lease after the new lease begins.
Court ruling date: May 16, 2025, in the U.S. District Court for the District of Delaware, covering both infringement and validity arguments
Defendants in the patent case: Aurobindo Pharma Limited and its affiliate, and MSN Laboratories Private Ltd. and its affiliate
210 Lease: about 52,771 square feet, term of 12 years and 2 months, commencing no later than January 1, 2026, with first-year payment of $1,899,756
Maximum landlord contribution of $5,277,100 for improvements, with a possible $2,638,550 supplemental contribution repayable with 8.00% interest
Keysight reported second-quarter fiscal 2025 revenue of $1.31 billion, up from $1.22 billion a year earlier, and non-GAAP earnings of $1.70 per share, up from $1.41. The company said revenue and EPS were above the high end of its guidance and raised its full-year growth expectations to the midpoint of its long-term 5-7% target. Separately, director Robert A. Rango retired from the board effective May 15, 2025, for personal reasons.
Q2 revenue was $1.31 billion versus $1.22 billion in Q2 2024; GAAP diluted EPS was $1.49 versus $0.72.
Non-GAAP diluted EPS was $1.70 versus $1.41 a year earlier; free cash flow was $457 million versus $74 million.
Third-quarter fiscal 2025 revenue is expected at $1.305 billion to $1.325 billion, with non-GAAP EPS of $1.63 to $1.69.
Director Robert A. Rango retired from the board effective May 15, 2025, for personal reasons, not due to a disagreement with the company.
ANI Pharmaceuticals filed an investor presentation for the H.C. Wainwright BioConnect conference on May 20, 2025, where CEO Nikhil Lalwani is scheduled to present. The deck restates the revised full-year 2025 guidance issued May 9, 2025, which raised net revenue to $768-793 million from $756-776 million and adjusted EBITDA to $195-205 million from $190-200 million, and describes this as the second guidance raise this year.
Full-year 2025 net revenue guidance is $768-793 million, up from $756-776 million; the deck calls this the second guidance raise in 2025.
Adjusted non-GAAP diluted EPS guidance is $6.27-6.62, up from $6.12-6.49.
Q1 2025 total revenue was $197 million, up 43% year over year; Q1 adjusted non-GAAP EBITDA was $51 million, up 35%.
CEO Nikhil Lalwani will present on May 20, 2025 at the H.C. Wainwright 3rd Annual BioConnect Investor Conference in New York.
Bath & Body Works appointed Daniel Heaf, formerly a leader at Nike, as chief executive effective May 16, 2025, and Gina Boswell left the CEO role and the Board that day. The company also pre-announced preliminary first-quarter results, with net sales up 3% and earnings per diluted share above the prior year, and kept its full-year 2025 outlook unchanged.
Daniel Heaf became CEO effective May 16, 2025, and will join the Board after the 2025 Annual Meeting of Shareholders; Gina Boswell stepped down as CEO and director the same day.
Preliminary first-quarter net sales were $1,424 million, up 3% from the prior year, at the high end of guidance.
Diluted EPS was $0.49, compared with $0.38 a year earlier, above the high end of guidance; results remain subject to closing procedures.
Full-year 2025 guidance was maintained at net sales growth of 1% to 3% and EPS of $3.25 to $3.60, reflecting the initial 10% tariff on goods imported from China.
Penske Automotive Group's board declared a quarterly dividend of $1.26 per share, up 3.3% from the prior quarter, and added $250 million to its securities repurchase authority, bringing the total to $295.8 million. The dividend is the company's 18th consecutive quarterly increase, and the filing also reports that all proposals at the May 14, 2025 annual meeting were approved.
Quarterly dividend of $1.26 per share, an increase of $0.04 (3.3%), payable June 3, 2025 to holders of record as of May 27, 2025
Additional $250 million in repurchase authority; total current authority is $295.8 million as of May 14, 2025
All proposals approved at the May 14, 2025 annual meeting, including election of 13 directors and ratification of Deloitte & Touche LLP for 2025
RBC Bearings reported fourth-quarter and full-year fiscal 2025 results for the periods ended March 29, 2025. Fourth-quarter net sales rose 5.8% to $437.7 million, and GAAP diluted EPS rose to $2.30 from $1.91, while full-year net sales rose 4.9% to $1,636.3 million and full-year GAAP diluted EPS rose to $7.70 from $6.41. The company also expects first-quarter fiscal 2026 net sales of $424.0 million to $434.0 million.
Fourth-quarter net sales of $437.7 million, up 5.8%; Aerospace/Defense up 10.6%, Industrial up 3.3%
Fourth-quarter GAAP diluted EPS of $2.30 versus $1.91 a year earlier; adjusted diluted EPS of $2.83 versus $2.47
Full-year fiscal 2025 GAAP diluted EPS of $7.70 versus $6.41; backlog of $940.7 million as of March 29, 2025
First-quarter fiscal 2026 outlook: net sales of $424.0 million to $434.0 million, growth of 4.4% to 6.8%
Royal Caribbean Cruises Ltd. amended its two unsecured revolving credit facilities on May 14, 2025, increasing commitments by $2.28 billion to a combined $6.35 billion and extending one facility's maturity from October 2026 to October 2030. The amendments also allow the company to raise total capacity to up to $8.35 billion under certain conditions, including receiving additional or increased lender commitments, which gives the company more borrowing capacity for shareholders to weigh against its debt obligations.
Commitments rose by $2.28 billion, or $1.14 billion per facility, bringing combined commitments to $6.35 billion.
The facility maturing in October 2026 now matures in October 2030; the other facility still matures in October 2028.
Total capacity can increase to up to $8.35 billion under certain conditions, including additional or increased lender commitments.
CFO Naftali Holtz said the upsizing reflects the strength of the company's credit profile and lender support.
CAVA Group reported fiscal first-quarter 2025 results for the 16 weeks ended April 20, 2025, with restaurant revenue up 28.2% and net income more than doubling to $25.7 million. The company also raised its fiscal 2025 guidance for adjusted EBITDA to $152.0 million to $159.0 million and for net new restaurant openings to 64 to 68.
CAVA restaurant revenue was $328.5 million, up 28.2% from $256.3 million, with same restaurant sales growth of 10.8%.
Net income was $25.7 million, or $0.22 per diluted share, compared with $14.0 million, or $0.12 per diluted share, a year earlier. Net income included a $10.7 million income tax benefit related to equity-based compensation.
Restaurant-level profit margin was 25.1%, compared with 25.2% a year earlier, as input costs and wage investments offset higher sales.
Fiscal 2025 adjusted EBITDA guidance was raised to $152.0 million to $159.0 million from $150.0 million to $157.0 million on May 15, 2025.
Doximity reported fourth-quarter and fiscal 2025 results for the period ended March 31, 2025, with revenue, net income and cash flow all higher than a year earlier. The company also issued revenue and adjusted EBITDA guidance for the fiscal first quarter and full fiscal 2026, which shareholders can compare against these results.
Q4 revenue of $138.3 million, up 17% from $118.1 million; Q4 net income of $62.5 million versus $40.6 million
Fiscal 2025 revenue of $570.4 million, up 20%; net income of $223.2 million versus $147.6 million
Q4 diluted net income per share of $0.31 versus $0.20; Q4 free cash flow of $97.0 million, up 56%
Fiscal 2026 guidance: revenue of $619 million to $631 million and adjusted EBITDA of $333 million to $345 million
STERIS reported fiscal 2025 full-year revenue from continuing operations up 6% to $5.5 billion and diluted EPS from continuing operations of $6.16, up from $5.55. Fourth-quarter as reported diluted EPS slipped to $1.48 from $1.54 after a $48.2 million Illinois EO litigation settlement charge. The company also gave fiscal 2026 guidance of 6-7% revenue growth and adjusted EPS of $9.90 to $10.15.
Q4 fiscal 2025 revenue rose 4% to $1.5 billion; as reported diluted EPS was $1.48 versus $1.54 a year earlier
Full-year adjusted diluted EPS was $9.22, up from $8.20 in fiscal 2024
Fiscal 2026 outlook: revenue up 6-7% and adjusted EPS of $9.90 to $10.15, with tariffs estimated to reduce pre-tax profit by about $30 million
Free cash flow for fiscal 2025 was $787.2 million, up from $620.3 million
Hawkins reported record fourth-quarter and full-year fiscal 2025 results, with full-year sales up 6% to $974.4 million and diluted EPS up 12% to $4.03. The company expects all segments to grow in fiscal 2026 and revenue to surpass $1 billion, but expects EPS growth to slow due to higher interest and amortization expense.
Fourth-quarter sales rose 10% to $245.3 million and diluted EPS rose to $0.78 from $0.66 a year earlier.
Full-year Water Treatment sales rose 23% to $446.5 million, while Industrial sales fell 7% and Health and Nutrition sales fell 1%.
Net debt ended the year at $143.9 million, with a leverage ratio of 0.86x adjusted EBITDA; the company expects it to fall below 1x by the end of fiscal 2027.
Fiscal 2026 EPS is expected to grow more slowly than in recent years, and the company will report under new segments starting in the first quarter of fiscal 2026.
Boot Barn reported fourth-quarter and fiscal 2025 results for the periods ended March 29, 2025, with net sales up 16.8% to $453.7 million and net income of $37.5 million, or $1.22 per diluted share, versus $0.96 a year earlier. The board also authorized up to $200 million in share repurchases, and the company gave fiscal 2026 guidance with diluted EPS of $5.50 to $6.40 against $5.88 in fiscal 2025.
Q4 net sales rose 16.8% to $453.7 million; consolidated same store sales rose 6.0%.
Fiscal 2025 net income was $180.9 million, or $5.88 per diluted share, up from $4.80.
Board authorized repurchases of up to $200 million of common stock with no expiration date.
Fiscal 2026 guidance: total sales of $2.070 billion to $2.150 billion and diluted EPS of $5.50 to $6.40.
Dynatrace reported fourth-quarter and full-year fiscal 2025 results for the period ended March 31, 2025, saying Q4 results exceeded guidance on all key operating metrics. Fiscal 2026 guidance calls for total revenue of $1,950 million to $1,965 million, and the company repurchased 787,000 shares for $43 million in Q4 under a $500 million buyback program.
Q4 total revenue of $445 million, up 17% (19% constant currency); Q4 GAAP EPS was $0.13, flat versus the prior-year quarter
Full-year fiscal 2025 total revenue of $1,699 million, up 19%; GAAP EPS of $1.59 includes a $320.9 million income tax benefit from an intra-entity IP transfer
Fiscal 2026 full-year guidance: total revenue of $1,950 million to $1,965 million and non-GAAP EPS of $1.56 to $1.59
Exelixis reported first-quarter 2025 total revenues of $555.4 million, up from $425.2 million a year earlier, and GAAP diluted earnings per share of $0.55, up from $0.12. The company raised its 2025 total revenue guidance by $100 million, to $2.25 billion to $2.35 billion, and net product revenue guidance to $2.05 billion to $2.15 billion, citing growth in CABOMETYX demand.
Q1 2025 total revenues were $555.4 million, versus $425.2 million in Q1 2024; net product revenues were $513.3 million.
GAAP diluted EPS was $0.55 and non-GAAP diluted EPS was $0.62, versus GAAP diluted EPS of $0.12 in Q1 2024.
2025 total revenue guidance is now $2.25 billion to $2.35 billion, up from $2.15 billion to $2.25 billion.
Stock repurchases totaled $494.5 million through March 31, 2025, at an average price of $34.87 per share.
Silicon Labs reported first-quarter 2025 results for the period ended April 5, 2025, with revenue of $178 million compared with $106 million a year earlier. The GAAP loss per share narrowed to $(0.94) from $(1.77), and the company expects second-quarter revenue of $185 million to $200 million.
Revenue was $178 million for the quarter ended April 5, 2025, versus $106 million for the quarter ended March 30, 2024.
GAAP diluted loss per share was $(0.94), compared with $(1.77) a year earlier; GAAP net loss was $30 million, versus $57 million.
Non-GAAP diluted loss per share was $(0.08).
Second-quarter outlook: revenue of $185 million to $200 million; non-GAAP diluted earnings (loss) per share of $(0.01) to $0.19.
StandardAero reported first-quarter 2025 revenue of $1.4 billion, up 16.2% from a year earlier, and net income of $62.9 million, compared with $3.2 million in the prior-year quarter. The company raised its full-year 2025 revenue and Adjusted EBITDA guidance, which now includes an estimated $15 million net impact from announced tariffs.
Revenue of $1,435.6 million, up 16.2% from $1,235.7 million; diluted EPS of $0.19 versus $0.01 a year earlier
Net income of $62.9 million, helped by $33.8 million lower interest expense than the prior-year quarter
2025 revenue guidance raised to $5.8 billion to $6.0 billion (from $5.8 billion to $6.0 billion prior range); Adjusted EBITDA guidance raised to $775 million to $795 million from $770 million to $790 million
Arrowhead Pharmaceuticals reported fiscal second-quarter 2025 results for the period ended March 31, 2025, with revenue of $542.7 million versus none a year earlier and net income attributable to the company of $370.4 million, compared with a loss of $125.3 million in the prior-year quarter. The company also said it expects to be funded into 2028 following its Sarepta Therapeutics agreement, and that its CFO, Ken Myszkowski, will retire effective May 13, 2025, succeeded by Daniel Apel.
Net income attributable to Arrowhead was $370.4 million, or $2.75 per diluted share, versus a loss of $1.02 per share a year earlier.
Research and development expenses rose to $133.1 million from $101.1 million.
CFO Ken Myszkowski retires effective May 13, 2025; Daniel Apel succeeds him.
Power Integrations reported first-quarter 2025 net revenue of $105.5 million, up 15% from a year earlier, and GAAP diluted earnings of $0.15 per share, up from $0.07. The board also authorized an additional $50 million for share repurchases, and the company forecast second-quarter revenue of $115 million, plus or minus $5 million, which would be above the first-quarter level.
Q1 2025 net revenues were $105.5 million, up 15% from Q1 2024 and up slightly from Q4 2024.
GAAP diluted EPS was $0.15 versus $0.07 in Q1 2024; non-GAAP diluted EPS was $0.31 versus $0.18.
Q2 2025 revenue is forecast at $115 million, plus or minus $5 million; GAAP gross margin about 55%.
Board authorized an additional $50 million for share repurchases after the company bought back $23.1 million of stock in Q1 and used the remaining $25 million in April.
Essential Utilities reported first-quarter 2025 net income of $283.8 million, or $1.03 per share, up from $265.8 million, or $0.97 per share, a year earlier. Revenue rose 28% to $783.6 million, mainly from regulatory recoveries, higher purchased gas costs and higher regulated natural gas volumes, and the company affirmed its 2025 EPS guidance of $2.07 to $2.11. Shareholders also have a quarterly dividend of $0.3255 per share, payable June 2, 2025 to holders of record on May 13, 2025.
Q1 2025 net income was $283.8 million, or $1.03 per diluted share, versus $265.8 million, or $0.97, in Q1 2024.
Operating revenues were $783.6 million, up 28% from $612.1 million.
2025 diluted EPS guidance of $2.07 to $2.11 was affirmed, and long-term targets were also affirmed.
Quarterly dividend of $0.3255 per share is payable June 2, 2025 to shareholders of record on May 13, 2025.
V2X's board authorized a share repurchase program of up to $100 million of common stock, effective May 12, 2025, with a three-year term ending May 12, 2028. Shareholders also approved an amended 2014 Omnibus Incentive Plan at the May 8, 2025 annual meeting, which adds 900,000 shares for issuance, while the company noted the buyback is not obligated and can be amended, suspended or discontinued at any time.
Board authorized up to $100 million in common stock repurchases on May 7, 2025, effective May 12, 2025
Program runs three years, ending May 12, 2028, and may be used through open market, block trades, privately negotiated deals or Rule 10b5-1 trading plans
Shareholders approved the Amended Omnibus Plan with 23,732,884 votes for and 5,322,908 against, adding 900,000 shares
Filing states the company is not required to repurchase any shares
Macerich reported first-quarter 2025 results on May 12, 2025. The net loss attributable to the company was $50.1 million, or $0.20 per diluted share, compared with $126.7 million, or $0.59 per share, a year earlier, while total revenues rose to $249.2 million from $208.8 million. FFO excluding certain items was $87.4 million, or $0.33 per share, the same per-share figure as a year earlier, but portfolio occupancy fell to 92.6% from 93.4%.
Total revenues were $249.2 million for the quarter, up from $208.8 million in the first quarter of 2024.
Net loss attributable to the company was $50.1 million ($0.20 per diluted share), versus $126.7 million ($0.59 per share) a year earlier.
FFO excluding certain items was $87.4 million ($0.33 per share), compared with $74.6 million ($0.33 per share).
Portfolio occupancy was 92.6% at March 31, 2025, down from 93.4% at March 31, 2024.
NHC reported first-quarter 2025 results for the quarter ended March 31, 2025. Net operating revenues rose 25.7% year over year to $373.7 million, driven by an 8.5% increase in same-facility revenue and the August 1, 2024 acquisition of White Oak Management, Inc. GAAP net income attributable to NHC increased to $32.2 million, or $2.07 per diluted share, from $26.2 million, or $1.69 per diluted share, a year earlier.
Net operating revenues were $373.7 million versus $297.2 million in the first quarter of 2024, an increase of 25.7%.
GAAP net income attributable to NHC was $32.2 million, compared with $26.2 million a year earlier.
Adjusted diluted EPS was $1.59 versus $0.99 a year earlier; adjusted net income was $24.8 million versus $15.4 million.
Same-facility net operating revenues rose 8.5%; the White Oak acquisition closed August 1, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.